Immunology stories

Sep 1, 2026

GSK advances mRNA flu vaccine to late-stage trial after strong mid-stage results

GSK will advance its mRNA-based seasonal influenza vaccine to late-stage trials after mid-stage data showed it generated stronger immune responses than currently approved flu vaccines.

Sep 1, 20262 sources

May 5, 2026

UCB Acquires Maker of Antibody Treatments for Autoimmune Diseases

Belgian pharmaceutical company UCB has announced the acquisition of a company specializing in antibody treatments for autoimmune diseases, expanding its immunology portfolio.

May 5, 20261 source

Apr 12, 2026

Researchers Discover Chloride Channel PACC1 as New Target for Sepsis Treatment

Scientists have identified a previously unknown immune mechanism where the chloride channel PACC1 plays a crucial role in helping immune cells kill bacteria, offering a potential new therapeutic target for sepsis.

Apr 12, 20261 source

Apr 11, 2026

COVID-19 Spike Protein Linked to Increased Lung Cancer Risk Through Inflammatory Pathway

New study suggests SARS-CoV-2 may slightly increase lung cancer risk by triggering a biological chain reaction driven by the virus's spike protein that promotes inflammation and tumor development.

Apr 11, 20261 source

Apr 7, 2026

High-Fat Diets Linked to Rapid Loss of Protective Gut Immune Cells

Mass General Brigham researchers found that even short-term exposure to high levels of dietary fat results in quick and selective loss of critical gut immune cells in preclinical study.

Apr 7, 20261 source

Apr 6, 2026

Mayo Clinic Develops Method to Identify Immune-Triggering Proteins in Transplants

Mayo Clinic researchers have developed a new method to identify which proteins are most likely to trigger an immune response, a discovery that could help improve transplant care and regenerative medicine outcomes.

Apr 6, 20261 source

Scripps Research Develops New Anti-Inflammatory Drug Class That Preserves Immune Function

Scripps Research scientists have developed a first-in-class drug compound that reduces harmful inflammation while leaving the body's ability to fight infections intact, addressing a long-sought goal in treating autoimmune diseases.

Apr 6, 20261 source

Apr 5, 2026

Research Team Discovers Dermcidin Exhibits Antiviral Activity Against Influenza

A research team led by the Fisabio Foundation has demonstrated that dermcidin, an antimicrobial peptide naturally produced by the human body, also shows antiviral activity against the influenza virus.

Apr 5, 20261 source

Top claims

▪GSK intends to begin the late-stage trial for its mRNA-based seasonal influenza vaccine candidate in September 2026
▪GSK stated that targeting both haemagglutinin and neuraminidase surface proteins could improve protection against seasonal influenza and reduce transmission
▪In August 2026, Moderna won U.S. approval for its seasonal flu vaccine mFlusiva, which is the first mRNA-based vaccine approved for seasonal flu

Topics

Clinical trials Drug Approval and Clinical Trials Vaccine development and innovation Pharma Autoimmune disease treatment Pharmaceutical Industry Infectious Disease and Outbreaks Inflammation reduction & immune effects Biomarkers & bloodwork testing Health Gut health & microbiome Nutrition fundamentals Fats Dietary patterns

Related entities

Influenza Vaccine Belgium Sepsis SARS-CoV-2 COVID-19 Lung cancer Nutrition Mass General Brigham Lupus Autoimmune disease Inflammation Rheumatoid arthritis